Fosun Pharmaceutical seeks $594 million from HK listing

Prudential agrees to buy $50 million worth of shares, bringing the total cornerstone investment to $75 million.

Fosun Pharmaceutical seeks $594 million from HK listing

Shanghai Fosun Pharmaceutical Group yesterday kicked off the institutional roadshow and bookbuilding for the first Hong Kong listing in three months and the biggest since Yitai Coal raised $902 million in early July. As such, the deal will be extremely important as a gauge of investor appetite for Chinese companies.

The private sector company is seeking to raise between HK$3.97 billion and HK$4.6 billion $512 million to $594 million from the sale of...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition


  • Green Bonds Southeast Asia

    25 May 2017  |  Singapore
    With Green Bonds globally reaching USD200 billion outstanding in 2016, from as little as 30bn just 4 years ago, can SE Asia corporations and ...
  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...